Fibrogammin (Human Plasma Coagulation FXIII)

 Fibrogammin (Factor XIII) is a product made from human plasma (this is the liquid part of the blood). This medication is used to prevent or halt bleeding caused by a deficiency of factor XIII in the blood, a condition present since birth (congenital FXIII deficiency). Factor XIII is required for forming blood clots, aiding in the cessation of bleeding, and promoting faster healing of wounds.

Recommended Dosage: The dosing regimen should be individualized based on body weight, laboratory values, and the patient’s clinical condition.

Congenital FXIII deficiency: The recommended initial dose is 40 International Units (IU)/kg body weight administered by injection under the skin or into a vein. Do not inject at a rate higher than 4 ml per minute. Subsequent dosing should be guided by the most recent trough FXIII activity level, with dosing every 28 days (4 weeks) to maintain a trough FXIII activity level of approximately 5 to 20%.

Prophylaxis before surgery: After the patient’s last routine prophylactic dose, if surgery is scheduled:

• Between 21 and 28 days later – administer the patient’s full prophylaxis dose immediately before surgery and the next prophylactic dose should be given 28 days later.
• Between 8 and 21 days later – an additional dose (full or partial) may be administered before surgery. The dosage should be based on the patient’s FXIII activity levels and clinical status and should be modified based on the Fibrogammin’s duration of action.
• Within 7 days of the last dose – additional dosing may not be needed.

• Fibrogammin may cause allergic reactions, including anaphylaxis, in some individuals. Patients with a history of hypersensitivity to human proteins or any component of Fibrogammin should exercise caution.
  
• Fibrogammin may increase the risk of thromboembolic events, such as deep vein thrombosis or pulmonary embolism. Patients with a history of thromboembolic disorders should be closely monitored during treatment.
  
• Patients receiving Fibrogammin may develop hypersensitivity reactions, including fever, chills, rash, and itching. If any signs of hypersensitivity occur, treatment should be discontinued immediately.
  
• Fibrogammin 250 IU is made from human plasma and may carry a risk of transmitting infectious agents, including viruses and prions. Donors of plasma used for the production of Fibrogammin are screened and tested to reduce this risk, but it cannot be eliminated.
  
• Fibrogammin may worsen thrombosis in patients with DIC. Use with caution in these patients, and monitor closely for signs of thrombosis or worsening coagulation abnormalities.

What documents are required to import FIBROGAMMIN to India?

FIBROGAMMIN (Coagulation factor XIII) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable

FIBROGAMMIN (Coagulation factor XIII) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Fibrogammin 250 IU in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of FIBROGAMMIN (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Fibrogammin 250 IU price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the FIBROGAMMIN (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Fibrogammin®?

Human Plasma Coagulation Factor XIII is a Generic Name for the trade name drug Fibrogammin®.

What is the Manufacturer’s Name of Fibrogammin®?

Fibrogammin® is manufactured by CSL Behring.

What is the dosage and form of Fibrogammin® supplied?

Fibrogammin® is supplied as powder and solvent for solution for injection/infusion: 250/1250 IU for IV administration. 

What are the most common side effects of Fibrogammin®? 

The most common side effects of Fibrogammin® are redness, warmth, and pain at the injection site.

How much does Fibrogammin® cost in India?

The cost of Fibrogammin 250 IU in India can vary. To procure this therapeutic drug legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Fibrogammin®?

Fibrogammin should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Do not freeze or shake the medication. Protect from light.

Is it safe to buy Fibrogammin® online in India?

Yes, one can buy Fibrogammin 250 IU online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Fibrogammin injections through legal channels.